In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for November 2012.

Pharmaceutical Technology
Volume 36, Issue 11, pp. 24

Manufacturing process intelligent software helps improve process predictability



The latest version of Aegis's Discoverant software can perform data aggregation, investigational analytics, and process modeling to improve process predictability and product quality. Discoverant 4.2 includes new features that were developed following input from Aegis customers, such as simplified user management and authentication with network-based group management, enhanced support for global collaboration across multiple time zones, new administrative reports, and greater control over query tools for easier model management. In addition, advanced analysis and data collection are made possible via the software's InVision and PRIMR features.

Aegis Analytical Corp.
http://aegiscorp.com/
Software is available worldwide

Asset management system offers condition-based monitoring capabilities



Honeywell Process Solutions' Asset Manager R410 version offers real-time, condition-based monitoring of equipment to assist in maintenance and reliability planning. The system integrates with IBM's Maximo and SAP enterprise asset management and computerized maintenance management systems. This integration allows maintenance and reliability planners to review the status and priority of equipment health and the severity of any failures, assign resources as well as raise and track work orders directly from Asset Manager. In addition, Honeywell's newest version of its Field Advisor tool, which helps mobile workers prioritize and execute field tasks, has been refreshed to provide efficient automation for rounds and inspections.

Honeywell Process Solutions
http://www.honeywellprocess.com/
System is available worldwide


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here